Compare VICI Properties Inc (VICI) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VICI Properties Inc vs State Street SPDR S&P Biotech ETF — how do they compare? VICI Properties Inc trades at $26.59 (market cap $29.55B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: VICI Properties Inc pays a 6.71% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, VICI Properties Inc nearer its low. Which is the better fit depends on your goals.
| VICI | XBI | |
|---|---|---|
Market Cap | $29.55B | — |
Sector | Real Estate | Broad Market / Factor |
52-Week High | $33.93 | $164.28 |
52-Week Low | $25.94 | $85.16 |
Enterprise Value | $46.77B | — |
Dividend Yield | 6.71% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VICI Properties Inc
VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.
Read more on VICI →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
